GLA and Fabry disease: Although the reduction of GALA activity is still debated as a potential, yet unconfirmed, risk factor aggravating other pathologic conditions and mechanisms leading to ESKD [18], differences between the two biomarkers across the entire SC were insignificant, and thus suggest another potentially FD-related pathogenetic mechanism.